Following positive clinical results, retatrutide, a novel peptide option for treating adult-onset diabetes , has secured conditional approval from Great Britain's Medicines and Healthcare Agency ( MHRA https://henrinrtg975960.qodsblog.com/41197140/retatrutide-medication-peptide-british-green-light-and-access